Merluzzi VJ - Search Results

1

Restoration of cyclophosphamide-induced suppression of thymus-derived cytotoxic cell generation by normal thymocytes.

Merluzzi VJ, Faanes RB, Choi YS. Merluzzi VJ, et al. Cancer Res. 1979 Sep;39(9):3647-54. Cancer Res. 1979. PMID: 157806

2

Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.

Faanes RB, Merluzzi VJ, Williams N, Tarnowski GS, Ralph P. Faanes RB, et al. Among authors: merluzzi vj. Cancer Res. 1979 Nov;39(11):4564-74. Cancer Res. 1979. PMID: 315269

3

Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.

Merluzzi VJ, Walker MM, Faanes RB. Merluzzi VJ, et al. Cancer Res. 1981 Mar;41(3):850-3. Cancer Res. 1981. PMID: 6450638

4

Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants.

Merluzzi VJ, Kenney RE, Schmid FA, Choi YS, Faanes RB. Merluzzi VJ, et al. Cancer Res. 1981 Sep;41(9 Pt 1):3663-5. Cancer Res. 1981. PMID: 6790167

5

Regulatory mechanisms in cytotoxic T lymphocyte development. I. A suppressor T cell subset that regulates the proliferative stage of CTL development.

Susskind BM, Merluzzi VJ, Faanes RB, Palladino MA, Choi YS. Susskind BM, et al. Among authors: merluzzi vj. J Immunol. 1983 Feb;130(2):527-32. J Immunol. 1983. PMID: 6217242

6

Effect of cytarabine on cytotoxic T-cell development.

Merluzzi VJ, Susskind BM, Faanes RB. Merluzzi VJ, et al. Cancer Treat Rep. 1982 Mar;66(3):535-40. Cancer Treat Rep. 1982. PMID: 6800655 No abstract available.

7

Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of LYT-1/2- helper cells.

Merluzzi VJ, Faanes RB, Choi YS. Merluzzi VJ, et al. Int J Immunopharmacol. 1980;2(4):341-4. doi: 10.1016/0192-0561(80)90034-x. Int J Immunopharmacol. 1980. PMID: 6970728

8

Anomalous killer cells: thymus cell dependency, precursor frequency, and response to immunosuppressive therapy.

Merluzzi VJ, Kenney RE, Last-Barney K, O'Reilly RJ, Faanes RB. Merluzzi VJ, et al. Clin Immunol Immunopathol. 1982 Jul;24(1):83-92. doi: 10.1016/0090-1229(82)90091-5. Clin Immunol Immunopathol. 1982. PMID: 7049474 No abstract available.

9

Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression.

Merluzzi VJ, Last-Barney K, Susskind BM, Faanes RB. Merluzzi VJ, et al. Clin Exp Immunol. 1982 Nov;50(2):318-26. Clin Exp Immunol. 1982. PMID: 6217933 Free PMC article.

10

Immunoenhancing activity of NPT 15392: a potential immune response modifier.

Merluzzi VJ, Walker MM, Williams N, Susskind B, Hadden JW, Faanes RB. Merluzzi VJ, et al. Int J Immunopharmacol. 1982;4(3):219-24. doi: 10.1016/0192-0561(82)90051-0. Int J Immunopharmacol. 1982. PMID: 7049973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters